News & Updates

Twelve weeks of treatment with the aldosterone synthase inhibitor lorundrostat proved efficacious and safe for lowering blood pressure (BP) in adults with uncontrolled hypertension, including those who were resistant to treatment, according to the phase III Launch-HTN trial.

A systematic review and meta-analysis conducted by researchers from the Chinese University of Hong Kong and Hong Kong Baptist University has shown that combining exercise with intermittent fasting (IF) is associated with greater reductions in fat mass and waist circumference (WC) as well as more substantial improvements in cardiometabolic health parameters in overweight and obese individuals than IF alone.